A study conducted in the Netherlands found that the frequency of follow-up after fertility-sparing surgery for cervical cancer can be tailored based on high-risk HPV tests and cytology. The study included 1462 patients and found that patients with high-grade cytology and positive high-risk HPV at the first follow-up had worse recurrence-free survival rates. Patients negative for high-risk HPV with normal or low-grade cytology at 6-24 months after surgery could be offered a prolonged follow-up interval of 6 months, reducing healthcare costs. The retrospective design of the study was a limitation, and the authors declared no competing interests. The study was published in the December 2023 issue of The Lancet Oncology.
Source link
Optimal Follow-up After Cervical Cancer Surgery
